Mark Schimel

Mark Schimel holds extensive experience in oncology marketing, currently serving as Executive Director at Eisai US since July 2013, where responsibilities have included overseeing oncology portfolio marketing, pipeline planning, and thought leader marketing. Previous roles at Eisai US encompassed management of various oncology marketing initiatives, including GI cancers and melanoma. Prior to this, Mark Schimel worked at Daiichi Sankyo from June 2007 to July 2013, progressing through several positions in hypertension and product management. Early career experience at Eli Lilly involved roles in pharmaceutical sales. Mark Schimel earned an MBA from Columbia Business School and holds a degree from Rutgers University.